The KFSHRC is conducting a pharmacogenetic analysis for 1,500 patients during

RIAD, Saudi Arabia, Oct. 22, 2024 (GLOBE NEWSWIRE) — Since the beginning of the King Faisal Specialist Hospital Research Center (KFSHRC) In September, drug use in a new medical study began a pharmacogenetic analysis for 1,500 patients in the coming years. I think it is one of the rare Patienten-DNS (genetic code) security systems, a price prediction for the Arzneimittelwirksamkeit and Auswahl der effective and safe treatment of ermöglichen. There are some of the best ways to develop the herkömmliche “Einheitsmodel”, which is a solitary prescription and dosage of treatment by all patients who have done an individual genetic research on the Arzneimittel-based method.

The history of patients, a pharmacogenetic analysis takes longer, but 70% of patients think that the gene works with other functional functions. The uninterrupted use of the general service for the forecast of the jewel analyzes on the Arzneimittel on the Grundlage-transformed Unterschiede. The risk of future risks with an unanswered order can be reduced, smoother processing is a problem and there is a clear focus on individual interrogations on the Arzneimittel ermöglicht were. Statistical data on the fact that 15% of the Klinikeinweisungen op een indefinite Arzneimittelwirkungen zurückzuführen sind, which are thus an erhebliche financial and personal Taxung for the welfare systems of the system.

During the Global Health Exhibition in Riyadh from October 21 to 23, the KFSHRC is a platinum sponsor teilnehmen and friends with a fair that often offers new innovations and solutions in general healthcare in the research medicine, one of the pharmacogenetic analyzes and the results en for a good Health care practices.

The pharmacogenetic service will be offered to patients in cardiology and neurology and will be implemented in April for organ transplant patients. The KFSHRC can provide this service in the context of simplifying personalization, individual healthcare institutions schrittweise on all medical devices and some gewährleisten, which high standards in the field of safety and prevention during the time ch that Verwendung der new global, witschaftlich nachgewiesenen Verfahrensweisen final contents.

The KFSHRC has won the Pharmaceutical Industry Patient Care Program first place award of the renowned 2024 Gartner Eye on Innovation Award. The KFSHRC would be established in the following years as the best academic Medizinzentrum in Nahen Osten and in Africa and on the Platz 20 to 250 best academic Medizinzentren weltweit and in the ranking of Brand Finance 2024 as the best economic market and in Nahen Osten anerkannt. Darüber would appear a year later on the list of the 250 best Krankenhäuser of Welt-geführt and by the Zeitschrift Newsweek in the list of the world’s best smart hospitals for the 2025 annual meeting.

Resources contact:
Essam AlZahrani
966 55 525 4429
(email protected)

A photo of this notification is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/681eae73-c846-42a3-bf59-2efbbe2cc040

Quelle Hugin